The earnings call presented a mixed picture with notable improvements in gross margin and adjusted EBITDA, supported by cost reductions. However, these were counterbalanced by significant declines in revenue across multiple segments and an ongoing debt dispute. The company is focusing on building a more resilient and profitable model despite a complex operating environment.
Company Guidance
During the Bioceres Crop Solutions Fiscal First Quarter 2026 earnings call, Federico Trucco, CEO, highlighted key financial metrics and strategic priorities. Despite a 17% decline in total revenues to $77.5 million, the company achieved a gross profit of $36 million, maintaining a robust gross margin expansion of 650 basis points to 47%. The company's adjusted EBITDA surged 61% to $13.6 million, driven by a $5.9 million reduction in operating costs. Bioceres is focused on maintaining a gross margin above 40%, reducing annual SG&A by $10-12 million, and achieving profitability with adjusted EBITDA above 20% of sales. The company also reported a significant decline in revenues from Crop Protection and Seed and Integrated Products segments, but noted improvements in cost efficiency and product mix. Current debt was reported at $188.7 million, with a net financial debt of $225.9 million, while the net debt to adjusted EBITDA ratio improved to 6.8x. The company is committed to operating with discipline, focusing on profitability, liquidity, and capital efficiency amid a challenging environment.
Gross Margin Expansion
Gross margin expanded significantly by 650 basis points to 47% compared to 40% in the same quarter last year, reflecting improved product mix and margin expansion.
Operating Profit and Adjusted EBITDA Improvement
A significant decline in SG&A costs resulted in meaningful improvements in operating profits and a 61% increase in adjusted EBITDA, reaching $13.6 million compared to $8.5 million in the same period last year.
SG&A Cost Reduction
Both variable and fixed SG&A costs declined significantly, achieving 50% of the top of the expected annualized savings range in just one quarter.
Improved Net Debt to Adjusted EBITDA Ratio
Despite the challenging environment, the net debt to adjusted EBITDA ratio improved to 6.8x.
Bioceres Crop Solutions (BIOX) Earnings, Revenues Date & History
The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
BIOX Earnings-Related Price Changes
Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 12, 2025
$1.87
$1.71
-8.56%
Sep 09, 2025
$2.67
$2.24
-16.10%
May 21, 2025
$4.65
$4.45
-4.30%
Feb 11, 2025
$5.55
$4.78
-13.87%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Bioceres Crop Solutions (BIOX) report earnings?
Bioceres Crop Solutions (BIOX) is schdueled to report earning on Feb 05, 2026, Before Open (Confirmed).
What is Bioceres Crop Solutions (BIOX) earnings time?
Bioceres Crop Solutions (BIOX) earnings time is at Feb 05, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.